Treating the elderly patient with chronic lymphocytic leukemia: current and emerging options
Zahra Mozaheb Department of Hematology-Oncology, Imam-Reza Hospital, Mashhad University of Medical Science, Mashhad, Iran Abstract: Management of cancer in the elderly is an increasingly common problem. The risk of chronic lymphocytic leukemia (CLL) increases significantly after the age of 65 year...
Guardado en:
Autor principal: | Mozaheb Z |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9b43d4f5c26243aa984dd63db201a4cd |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The expanding role of bendamustine in chronic lymphocytic leukemia
por: Nair KS, et al.
Publicado: (2015) -
Targeting CD20 in chronic lymphocytic leukemia
por: Nahas MR, et al.
Publicado: (2015) -
Coexistence of primary myelofibrosis and chronic lymphocytic leukemia
por: Burgstaller S, et al.
Publicado: (2014) -
Pharmacology and clinical potential of oblimersen sodium in the treatment of chronic lymphocytic leukemia
por: O'Brien S, et al.
Publicado: (2012) -
Imatinib in the treatment of chronic myeloid leukemia: current perspectives on optimal dose
por: Waclaw J, et al.
Publicado: (2015)